Cambridge consultants predicts emerging market to transform global surgical care

16 August 2016 (Last Updated August 16th, 2016 18:30)

A report by Cambridge Consultants suggests that innovations and technical advances made in emerging market will reshape the delivery of surgical care by 2030.

A report by Cambridge Consultants suggests that innovations and technical advances made in emerging market will reshape the delivery of surgical care by 2030.

The report is based on the findings of a workshop recently held in Boston by Cambridge Consultants which analysed the effects of advances made in the healthcare system on the existing quality of surgical care.

Cambridge Consultants surgical innovation for emerging markets head Rahul Sathe said: “More than 85% of the world’s population lives in emerging markets, yet many of these people have no access to affordable quality healthcare, particularly complex treatment like surgery.

"Local emerging market companies may provide stiff competition to multinational companies but they may also prove to be powerful partners in global surgical care."

“Inadequate hospital infrastructure, a scarcity of qualified clinicians and fragmented healthcare ecosystems prevent successful surgical care.

“The surgical device industry has unprecedented growth opportunity to address the unmet needs of very large patient populations.”

The report emphasised the growth on affordable technology for early diagnosis; portable modular equipment for minimally invasive and robotic surgery; and smart systems incorporating low-cost sensors and mobile technology to track clinical outcomes and improve team-based surgery.

The technology is predicted to expand the hospital services starting from early diagnosis and surgical intervention to postoperative monitoring.

It is also expected to the usability and affordability of the products.

Quoting the advancement of hospitals in India and China which replicates the emerging market, the workshop delegates stated that the patient expectations and hospital ecosystems in the emerging market are expected to evolve outshining the developed medical care markets.

Boston Scientific Latin America marketing manager and workshop delegate Agustin Zabulanes said: “Emerging markets will play a significant role in transforming our industry.

“Local emerging market companies may provide stiff competition to multinational companies but they may also prove to be powerful partners in global surgical care.

“Success will require industry players to evolve the way they do business, organise for innovation and use enabling technology.”

The report also suggested that reverse innovation will allow the developed markets to learn new approaches from emerging markets to achieve an affordable and efficient healthcare integrated with new business models and innovation models.